Potentially, the recently described biochemical alterations, such as the lack of acetylated tau in the inclusions in AGD [115], or differences in phosphorylation of tau epitopes in tangles [38] or of C-terminal fragments and trypsin-resistant band patterns in tauopathies [39] might be developed to allow better grouping. The gene discussed is MAPT; the disease is argyrophilic grain disease.